Dermatology News

The rare occurrence of a scabies outbreak in the NICU of a children’s hospital underscored just how difficult the disease is to diagnose and treat in that setting, according to researchers.

Enthesitis is common among patients with psoriatic arthritis and psoriasis, as well as individuals with fibromyalgia who undergo a clinical examination only, according to findings published in the Journal of Rheumatology.

CHICAGO — The availability of biosimilars introduces market competition that reduces the cost of biosimilars, even in situations where the actual cost of the biosimilar is higher than that of its reference product, according to Jonathan Kay, MD, of the University of Massachusetts Medical School.

Overweight and obesity in young adults were inversely associated with acne, leading researchers to suggest that metabolically active adipose tissue plays a protective role in acne.

CHICAGO — Although rheumatologists have enjoyed an improved understanding of the pathogenesis of psoriatic arthritis, none of the newer drugs have proved superior to traditional therapies, according to Elaine Husni, MD, MPH, of the Cleveland Clinic.

CHICAGO — Nail enthesitis potentially offers an “intriguing gateway” connecting the appendicular system to the skeletal manifestations of psoriatic arthritis, according to a presenter at the 2019 Interdisciplinary Autoimmune Summit.

CHICAGO — Although previous results from the CANTOS study have demonstrated that targeting inflammation could significantly improve cardiovascular mortality outcomes, the drug its researchers used to test their hypothesis, canakinumab, comes with its own host of issues and is “not ready for prime time,” according to Leonard H. Calabrese, DO, vice chairman of rheumatic and immunologic disease at the Cleveland Clinic.

Taltz demonstrated high levels of efficacy and safety for the treatment of psoriasis over 4 years, according to research presented at the American Academy of Dermatology Annual Meeting.

A Danish cohort study revealed that nearly one-in-four patients with inflammatory bowel disease have another immune mediated inflammatory disease which can impact disease course and increase severity.

There is no substantial difference in the risks for atrial fibrillation and major adverse cardiovascular events between ustekinumab and TNF inhibitors among patients with psoriatic arthritis or psoriasis, according to data published in JAMA Dermatology.